ArticleScientific reports2026

Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis.

Arshdeep Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.